mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.071 |
0.1 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.075 |
0.1 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.1 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.1 |